Image may be NSFW.
Clik here to view.
Clik here to view.
Novel Pulmonary Hypertension Drug From Bayer Shows Modest Promise In Phase 3...
A new drug appears to have promising– but not game-changing– effects in people with two forms of pulmonary hypertension. Riociguat, a soluble guanylate cyclase stimulator under development by Bayer, is...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Positive Results For New Oral Drug From Actelion
Actelion has announced positive top-line results for a phase III trial of a new oral drug for the treatment of pulmonary arterial hypertension (PAH). The drug, selexipag, is a first-in-class orally...
View Article
More Pages to Explore .....
